RCAG
BIIB icon

Rehmann Capital Advisory Group’s Biogen BIIB Stock Holding History

Rehmann Capital Advisory Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$267K Buy
1,236
+71
+6% +$13.6K 0.01% 600
2026
Q1 		$214K Buy
+1,165
New +$215K 0.01% 632
2020
Q4 		– Sell
-740
Closed -$210K – 485
2020
Q3 		$210K Buy
+740
New +$206K 0.03% 397
2019
Q3 		$146K Buy
626
+26
+4% +$6.05K 0.02% 371
2019
Q2 		$140K Buy
600
+26
+5% +$6K 0.02% 510
2019
Q1 		$136K Sell
574
-49
-8% -$15.4K 0.02% 508
2018
Q4 		$187K Sell
623
-18
-3% -$5.74K 0.03% 258
2018
Q3 		$226K Buy
641
+7
+1% +$2.41K 0.03% 372
2018
Q2 		$184K Sell
634
-24
-4% -$6.75K 0.03% 398
2018
Q1 		$180K Buy
658
+5
+0.8% +$1.55K 0.03% 397
2017
Q4 		$208K Buy
653
+3
+0.5% +$962 0.04% 365
2017
Q3 		$204K Buy
+650
New +$192K 0.04% 359
2016
Q4 		– Sell
-703
Closed -$220K – 384
2016
Q3 		$220K Sell
703
-183
-21% -$54.2K 0.04% 324
2016
Q2 		$214K Buy
886
+115
+15% +$30.3K 0.04% 336
2016
Q1 		$201K Sell
771
-469
-38% -$124K 0.04% 335
2015
Q4 		$380K Sell
1,240
-65
-5% -$18.7K 0.08% 192
2015
Q3 		$381K Sell
1,305
-174
-12% -$57.5K 0.09% 184
2015
Q2 		$597K Buy
1,479
+5
+0.3% +$2.01K 0.14% 134
2015
Q1 		$622K Buy
1,474
+66
+5% +$26K 0.14% 136
2014
Q4 		$478K Sell
1,408
-1
-0.1% -$324 0.11% 158
2014
Q3 		$466K Buy
1,409
+22
+2% +$7.25K 0.11% 156
2014
Q2 		$437K Buy
1,387
+202
+17% +$60.8K 0.1% 163
2014
Q1 		$362K Buy
1,185
+34
+3% +$10.8K 0.1% 169
2013
Q4 		$322K Buy
1,151
+132
+13% +$34.1K 0.1% 190
2013
Q3 		$245K Buy
+1,019
New +$228K 0.08% 220

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rehmann Capital Advisory Group's BIIB Position: Q2 2026 in Review

Rehmann Capital Advisory Group increased its Biogen (BIIB) stake by 6.1% in Q2 2026, buying an estimated $13.6K and bringing the position to 1,236 shares worth $267K. The position accounts for 0.01% of the portfolio, ranked #600.

Rehmann Capital Advisory Group first reported a position in BIIB in Q3 2013 and has held it in 25 quarters since. The position peaked at $622K in Q1 2015. 1,045 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Rehmann Capital Advisory Group held 1,236 shares of Biogen worth $267K as of Q2 2026.
  • Rehmann Capital Advisory Group bought 71 Biogen shares in Q2 2026, an estimated $13.6K.
  • Biogen made up 0.01% of Rehmann Capital Advisory Group's portfolio in Q2 2026, its #600 holding.
  • Rehmann Capital Advisory Group first reported a position in Biogen in Q3 2013 and has held it in 25 quarters since.
  • Rehmann Capital Advisory Group's Biogen position peaked at $622K in Q1 2015.
  • 1,045 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Rehmann Capital Advisory Group's 13F filing for Q2 2026, filed 20 Aug 2026.